DEA Bans a Drug Some Opioid Users Called Miraculous, Stalling Research

The Drug Enforcement Administration has placed a substance on the Schedule I list, a category reserved for drugs considered to have no accepted medical use and high abuse potential. The drug had reportedly been described by some opioid users as a miracle treatment for their dependence. Researchers warn that the Schedule I classification could effectively halt studies of what they view as a promising opioid treatment. Critics argue the move restricts scientific investigation at a time when new options for opioid addiction are urgently needed. The ban underscores the tension between drug enforcement policy and the pursuit of potential medical breakthroughs.